Bormioli Pharma issues a binding offer to acquire GCL Pharma

Bormioli Pharma’s move to become a strong player in primary pharma packaging

156
Photo - Bormioli Pharma

Bormioli Pharma announces today the issuing of a Binding Offer for the acquisition of 100% of GCL Pharma, an Italian subsidiary of the Guala Closures Group, specialized in the production of plastic, rubber and aluminum closures for pharmaceutical applications.

Bormioli Pharma, a company leader in the production of pharmaceutical glass and plastic primary packaging, continues investing to become a stronger player in the sector.

This further acquisition that follows the one of Remy and Geiser completed last Autumn would allow the company to enlarge its product range, consolidating its ability to support the most demanding Pharma players.

In 2019 GCL Pharma recorded a turnover of approximately Euro 8 million (approximately Rs 65 crore). Over the years, the company has demonstrated strong innovation capabilities by continuously improving its product range to meet the most stringent pharma standards. The company’s main premises and production plant are located in Vasto (Chieti). The aggregate purchase price offered for the acquisition is Euro 8.9 million (approximately Rs 65 crore).

Andrea Lodetti, chief executive officer of Bormioli Pharma, said, “With the acquisition of GCL Pharma, we will continue our growth path. We aim to strengthen our industrial footprint by adding new technologies that allow extending our product range, especially in the oral and parenteral segments, activating further business synergies.”

Marco Giovannini, group chairman and chief executive officer of Guala Closure Group commented, “This disposal will allow the Guala Closures Group to fully focus on its core business, and specifically on high-value closures with increased growth prospective, including connected closures”.

Closing of the transaction is expected in the next few weeks.

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here